Breakthrough in Bacterial Cancer Therapy: Japanese Scientists Discover Tumor-Targeting Bacterium
Scientists at the Japan Advanced Institute of Science and Technology (JAIST) have discovered a naturally occurring bacterium from Japanese tree frogs that eliminates tumors in mice, according to a study published in Gut Microbes. The strain, Ewingella americana, achieved a 100% complete response rate in colorectal cancer models, outperforming standard treatments like immunotherapy and chemotherapy.
How the Bacterium Targets Tumors
Ewingella americana thrives in low-oxygen environments, allowing it to multiply within tumors. In mouse trials, the bacteria increased 3,000-fold within 24 hours, directly damaging cancer cells. Researchers attribute its specificity to tumor characteristics: low oxygen, leaky blood vessels, and unique metabolic signals that attract the bacterium while sparing healthy tissue.
Safety and Efficacy in Mouse Models
The treatment cleared tumors without long-term side effects. E. americana was undetectable in organs after 24 hours, with only mild inflammation observed. Over 60 days, no chronic toxicity was recorded, suggesting a favorable safety profile compared to conventional cancer drugs.
Future Applications and Research Directions
Researchers plan to test the bacterium against breast, pancreatic, and melanoma tumors. They also aim to refine delivery methods, such as direct tumor injection, and explore combinations with chemotherapy or immunotherapy. The study highlights biodiversity as a potential source of novel treatments, particularly for hard-to-treat cancers.
Did You Know?
FAQ: Answers to Common Questions
What makes this bacterium different from other cancer treatments?
Unlike immunotherapies or chemotherapy, E. americana directly targets tumors using a dual mechanism: attacking cancer cells and activating the immune system. It also avoids healthy tissues, reducing side effects.
Can this treatment work in humans?
The study was conducted in mice, and human trials are not yet underway. Researchers caution that results may not translate directly, but the findings provide a strong foundation for further investigation.
How was the bacterium discovered?
Scientists collected 45 bacterial strains from Japanese tree frogs, newts, and lizards. After screening for anticancer properties, E. americana showed the most promise in preclinical models.
Pro Tips for Readers
Stay informed about emerging cancer therapies by following updates from JAIST and Gut Microbes. Discuss potential advancements with your healthcare provider as research evolves.
Have questions about bacterial therapies or cancer treatment trends? Explore our FAQ section or share your thoughts below.
Worth a look